Cardiol Therapeutics (TSE:CRDL) Shares Up 1% - Here's Why

Cardiol Therapeutics Inc. (TSE:CRDL - Get Free Report) was up 1% during mid-day trading on Friday . The company traded as high as C$2.08 and last traded at C$2.07. Approximately 77,015 shares traded hands during mid-day trading, an increase of 6% from the average daily volume of 72,656 shares. The stock had previously closed at C$2.05.

Cardiol Therapeutics Stock Down 3.6%

The company has a market capitalization of C$157.66 million, a price-to-earnings ratio of -3.73 and a beta of 0.70. The company has a quick ratio of 6.84, a current ratio of 2.49 and a debt-to-equity ratio of 1.59. The business has a 50-day moving average price of C$1.75 and a 200-day moving average price of C$1.70.

About Cardiol Therapeutics

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis.